Pharmacokinetic Study of Tranexamic Acid

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

August 31, 2025

Conditions
Ovarian Neoplasm Epithelial
Interventions
BEHAVIORAL

Tranexamic acid Intravenous Infusion

A slow intravenous infusion of 1g TXA was administered at a rate of about 1ml/min.

BEHAVIORAL

TXA intramuscular injection

5ml intramuscular injections of TXA with twice, each injection time no more than 30 seconds, the injection site was selected as triangle

Trial Locations (1)

310022

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
lead

Zhejiang Cancer Hospital

OTHER